Valby, Denmark

Jan Egebjerg

This inventor holds 9 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: H. Lundbeck A/s, Immunobrain Checkpoint, Inc., Yeda Research and Develpment & Co. Ltd. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Egebjerg. Retrieved from https://idiyas.com/inventor/jan-egebjerg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

 

Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Jan Egebjerg - Innovative Danish Inventor

Introduction: Jan Egebjerg is a renowned inventor hailing from Valby, Denmark, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Jan Egebjerg holds several patents in the areas of biotechnology, pharmaceuticals, and medical devices, showcasing his versatility and expertise in inventing cutting-edge solutions.

Career Highlights: Throughout his career, Jan Egebjerg has been instrumental in developing revolutionary technologies that have significantly impacted the healthcare industry, improving the quality of life for many individuals worldwide.

Collaborations: Jan Egebjerg has collaborated with leading research institutions and pharmaceutical companies to further advance his inventions, demonstrating his commitment to driving innovation through strategic partnerships.

Conclusion: Jan Egebjerg's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a pioneering inventor in Denmark and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…